...
首页> 外文期刊>Prehospital emergency care >Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts
【24h】

Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts

机译:阿片类药物过量复苏期间紧急医疗服务使用纳洛酮

获取原文
获取原文并翻译 | 示例
           

摘要

Naloxone administration is an important component of resuscitation attempts by emergency medical services (EMS) for opioid drug overdoses. However, EMS providers must first recognize the possibility of opioid overdose in clinical encounters. As part of a public health response to an outbreak of opioid overdoses in Rhode Island, we examined missed opportunities for naloxone administration and factors potentially influencing EMS providers' decision to administer naloxone. We reviewed medical examiner files on all individuals who died of an opioid-related drug overdose in Rhode Island from January 1, 2012 through March 31, 2014, underwent attempted resuscitation by EMS providers, and had records available to assess for naloxone administration. We evaluated whether these individuals received naloxone as part of their resuscitation efforts and compared patient and scene characteristics of those who received naloxone to those who did not receive naloxone via chi-square, t-test, and logistic regression analyses. One hundred and twenty-four individuals who underwent attempted EMS resuscitation died due to opioid overdose. Naloxone was administered during EMS resuscitation attempts in 82 (66.1%) of cases. Females were nearly three-fold as likely not to receive naloxone as males (OR 2.9; 95% CI 1.2-7.0; p-value 0.02). Additionally, patients without signs of potential drug abuse also had a greater than three-fold odds of not receiving naloxone (OR 3.3; 95% CI 1.2-9.2; p-value 0.02). Older individuals, particularly those over age 50, were more likely not to receive naloxone than victims younger than age 30 (OR 4.8; 95% CI 1.3-17.4; p-value 0.02). Women, older individuals, and those patients without clear signs of illicit drug abuse, were less likely to receive naloxone in EMS resuscitation attempts. Heightened clinical suspicion for opioid overdose is important given the recent increase in overdoses among patients due to prescription opioids.
机译:纳洛酮的给药是紧急医疗服务(EMS)进行阿片类药物过量用药复苏尝试的重要组成部分。但是,EMS提供者必须首先认识到在临床上遇到阿片类药物过量的可能性。作为对罗德岛地区阿片类药物过量爆发的公共卫生应对措施的一部分,我们检查了纳洛酮管理错失的机会以及可能影响EMS提供者决定采用纳洛酮的因素。我们审查了从2012年1月1日至2014年3月31日在罗德岛死于阿片类药物相关药物过量的所有个人的医疗检查员档案,并由EMS提供者进行了尝试复苏的治疗,并提供了可用于纳洛酮给药评估的记录。我们评估了这些人是否将纳洛酮作为其复苏工作的一部分,并通过卡方检验,t检验和逻辑回归分析比较了接受纳洛酮治疗的患者和未接受纳洛酮治疗的患者和患者的特征。尝试进行EMS复苏的124个人因阿片类药物过量而死亡。尝试进行EMS复苏时使用纳洛酮治疗的病例为82(66.1%)。女性不接受纳洛酮的几率是男性的三倍(OR 2.9; 95%CI 1.2-7.0; p值0.02)。此外,没有潜在药物滥用迹象的患者也有不接受纳洛酮的几率大于三倍(OR 3.3; 95%CI 1.2-9.2; p值0.02)。与30岁以下的受害人相比,年龄较大的个人,尤其是50岁以上的人,不接受纳洛酮的可能性更高(OR 4.8; 95%CI 1.3-17.4; p值0.02)。妇女,老年人和没有明显滥用药物迹象的患者,在EMS复苏尝试中接受纳洛酮的可能性较小。鉴于最近由于处方阿片类药物引起的患者用药过量增加,增加对阿片类药物过量的临床怀疑非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号